文献速递头颈外科

临床侵袭性甲状腺乳头状癌单侧与双侧中央颈淋巴结清扫术的比较

Comparison of unilateral versus bilateral central neck dissection for clinically invasive papillary thyroid carcinoma.
PubMed 文献 · Head Neck · 2024-07-09

研究纳入330例晚期甲状腺乳头状癌行全甲状腺切除加中央颈清扫的患者,其中单侧中央颈清扫212例、双侧118例,经1:1倾向评分匹配后各99对。随访47.8±20.4个月,全队列29例(8.8%)出现局部区域复发;匹配后两组无复发生存无显著差异(log-rank p=0.516)。多因素分析仅T4分期为局部区域复发的独立危险因素(p=0.006)。作者认为双侧中央颈清扫无预后获益,单侧中央颈清扫可能是临床侵袭性甲状腺乳头状癌的首选。

要点

  • 匹配后单侧与双侧中央颈清扫的无复发生存无显著差异(log-rank p=0.516)。
  • 双侧组获取的总中央淋巴结均数(14.1 vs 9.3,p<0.001)和转移中央淋巴结均数(6.8 vs 4.6,p=0.005)均显著多于单侧组。
  • 多因素分析仅T4分期为局部区域复发的独立危险因素(p=0.006)。

核心结论

  • 本研究显示双侧中央颈清扫无预后获益,单侧中央颈清扫可能是临床侵袭性甲状腺乳头状癌的首选。

研究设计与样本

  • 连续纳入330例因晚期甲状腺乳头状癌行全甲状腺切除加中央颈清扫的患者,其中单侧中央颈清扫212例(单侧组)、双侧中央颈清扫118例(双侧组)。
  • 采用1:1倾向评分匹配,得到99对匹配病例,比较两组手术结局与安全性,并用生存分析比较手术对局部区域复发的影响。

主要发现

  • 随访47.8±20.4个月,全研究队列29例(8.8%)出现局部区域复发。
  • 倾向评分匹配后,两组无复发生存无显著差异(log-rank p=0.516)。
  • 多因素分析显示仅T4分期为局部区域复发的独立危险因素(p=0.006)。
  • 双侧组获取的总中央淋巴结均数显著多于单侧组(14.1 vs 9.3,p<0.001),转移中央淋巴结均数亦显著多于单侧组(6.8 vs 4.6,p=0.005)。
  • 两组术后刺激状态下甲状腺球蛋白水平无显著差异(0.79 ng/mL vs 1.44 ng/mL,p=0.389)。

临床怎么用

  • 作者认为,单侧中央颈清扫可能是临床侵袭性甲状腺乳头状癌的首选。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American Thyroid Association guidelines primarily recommend central neck dissection for papillary thyroid carcinoma with advanced primary tumors or clinically positive neck nodes. However, the appropriate extent of dissection remains unclear. We aimed to compare the rate of locoregional recurrence between unilateral and bilateral central neck dissection in invasive papillary thyroid carcinoma. METHODS: Among 330 consecutive patients who underwent total thyroidectomy with central neck dissection for advanced papillary thyroid carcinoma, 212 underwent unilateral central neck dissection (UCND group) while 118 underwent bilateral central neck dissection (BCND group). We performed 1:1 propensity score matching, resulting in 99 matched pairs. Surgical outcomes and safety were compared between the two groups. Additionally, the impact of surgery on locoregional recurrence was compared using survival analysis. RESULTS: During a follow-up of 47.8 ± 20.4 months, 29 (8.8%) patients experienced locoregional recurrence within the entire study cohort. Following propensity score matching, no significant difference in recurrence-free survival was observed between the two groups (log-rank p = 0.516). Multivariate analysis revealed that only T4 staging was an independent risk factor for locoregional recurrence (p = 0.006). The mean number of total and metastatic central lymph nodes retrieved were significantly greater in BCND group (14.1 vs. 9.3, p < 0.001 and 6.8 vs. 4.6, p = 0.005, respectively). There was no significant difference in postoperative stimulated thyroglobulin levels between the two groups (0.79 ng/mL vs. 1.44 ng/mL, p = 0.389). CONCLUSION: The present study demonstrates no prognostic benefit in conducting bilateral central neck dissection. Unilateral central neck dissection may be the preferred choice for clinically invasive papillary thyroid carcinoma.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Min L, Weng Y, Li Y, et al. Comparison of unilateral versus bilateral central neck dissection for clinically invasive papillary thyroid carcinoma. Head Neck. 2024. PMID: 38979747. doi:10.1002/hed.27865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。